{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:04:44Z","timestamp":1793984684652,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Long non-coding RNAs (lncRNAs) play vital roles in tumor progression and resistance. Ovarian cancer (OC), a common gynecological cancer, is associated with poor prognosis as it can progress to peritoneal metastasis and develop resistance to chemotherapy. This study aimed to examine the role of lncRNAs in the development of chemotherapy resistance in OC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The clinical samples were divided into chemotherapy-sensitive and chemotherapy-resistant groups based on the chemotherapy response at follow-up. The glycolysis levels in the two groups were analyzed using positron emission tomography\/computed tomography (PET\/CT) scanning and immunohistochemistry. GEO dataset analysis revealed the expression of CTSLP8 in chemotherapy-resistant patients with OC. Two pairs of normal and diamminodichloroplatinum (DDP)-resistant cells were transfected with CTSLP8 overexpression and knockdown constructs to examine the functions of CTSLP8 in the OC cells and elucidate the underlying mechanisms. The in vivo effect of CTSLP8 overexpression and knockdown on the chemotherapy response of tumors was examined using a mouse subcutaneous tumor model. The tissue chips were subjected to fluorescence in situ hybridization and immunohistochemical (IHC) staining to examine the correlation among CTSLP8 expression, DDP resistance, and prognosis in OC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The dataset analysis demonstrated that CTSLP8 was upregulated in chemotherapy-resistant tumor tissues. CTSLP8 promoted the proliferation and development of DDP resistance in the OC cells. Moreover, CTSLP8 promoted c-Myc expression by facilitating the binding of PKM2 to the promoter region of c-Myc, thereby upregulating glycolysis. The analysis of tissue chips revealed that the upregulation of CTSLP8 was associated with the development of DDP resistance and poor prognosis in patients with OC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings indicate that CTSLP8 forms a complex with PKM2 to regulate c-Myc, and this action results in the upregulation of cellular glycolysis, consequently promoting OC progression and development of chemotherapy resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Headlights<\/jats:title>\n                <jats:p>1. CTSLP8 was upregulated in the chemotherapy-resistant tumor tissues.<\/jats:p>\n                <jats:p>2. CTSLP8 promoted the proliferation and cisplatin resistance in the OC cells.<\/jats:p>\n                <jats:p>3. CTSLP8 promoted glycolysis by facilitating the binding of PKM2 to the promoter region of c-Myc.<\/jats:p>\n                <jats:p>4. Inhibition of CTSLP8 or the combination of c-Myc inhibitors with cisplatin were potential therapeutic strategies for chemotherapy-resistant of OC.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s10565-021-09650-9","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T13:05:37Z","timestamp":1631451937000},"page":"1027-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2"],"prefix":"10.1007","volume":"38","author":[{"given":"Xiaoduan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feikai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-5887","authenticated-orcid":false,"given":"Ziliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,12]]},"reference":[{"key":"9650_CR1","first-page":"502","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB. \u201cOvarian cancer: strategies for overcoming resistance to chemotherapy\u201d, Nature reviews. Cancer. 2003;3:502\u201316.","journal-title":"Cancer"},{"key":"9650_CR2","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1073\/pnas.1702663114","volume":"114","author":"C Bouvard","year":"2017","unstructured":"Bouvard C, Lim SM, Ludka J, Yazdani N, Woods AK, Chatterjee AK, Schultz PG, Zhu S. Small molecule selectively suppresses MYC transcription in cancer cells. Proc Natl Acad Sci USA. 2017;114:3497\u2013502.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9650_CR3","first-page":"191","volume":"21","author":"SW Cheetham","year":"2020","unstructured":"Cheetham SW, Faulkner GJ, Dinger ME. \u201cOvercoming challenges and dogmas to understand the functions of pseudogenes\u201d, Nature reviews. Genetics. 2020;21:191\u2013201.","journal-title":"Genetics"},{"key":"9650_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","volume":"21","author":"F Chen","year":"2019","unstructured":"Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, Tu Q, Yin D, Lin D, Wong PP, Huang D, Xing Y, Zhao J, Li M, Liu Q, Su F, Su S, Song E. Extracellular vesicle-packaged HIF-1\u03b1-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21:498\u2013510.","journal-title":"Nat Cell Biol"},{"key":"9650_CR5","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.7150\/thno.40659","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Wan L, Wang W, Xi WJ, Yang AG, Wang T. Re-recognition of pseudogenes: From molecular to clinical applications. Theranostics. 2020;10:1479\u201399.","journal-title":"Theranostics"},{"key":"9650_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149:22\u201335.","journal-title":"Cell"},{"key":"9650_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13046-019-1306-9","volume":"38","author":"P Dong","year":"2019","unstructured":"Dong P, Xiong Y, Yue J, Xu D, Ihira K, Konno Y, Kobayashi N, Todo Y, Watari H. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes. J Exp Clin Cancer Res. 2019;38:295\u2013302.","journal-title":"J Exp Clin Cancer Res"},{"key":"9650_CR8","doi-asserted-by":"crossref","unstructured":"Elbadawy, M., T. Usui, H. Yamawaki, and K. Sasaki. 2019. Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer. Int J Mol Sci. 20.","DOI":"10.3390\/ijms20092340"},{"key":"9650_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","volume":"9","author":"A Gupta","year":"2018","unstructured":"Gupta A, Ajith A, Singh S, Panday RK, Samaiya A, Shukla S. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death Dis. 2018;9:825.","journal-title":"Cell Death Dis"},{"key":"9650_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.molcel.2020.05.004","volume":"78","author":"PP Hou","year":"2020","unstructured":"Hou PP, Luo LJ, Chen HZ, Chen QT, Bian XL, Wu SF, Zhou JX, Zhao WX, Liu JM, Wang XM, Zhang ZY, Yao LM, Chen Q, Zhou D, Wu Q. Ectosomal PKM2 Promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment. Mol Cell. 2020;78:1192-206.e10.","journal-title":"Mol Cell"},{"key":"9650_CR11","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1021\/acs.jmedchem.7b01697","volume":"61","author":"MH Hu","year":"2018","unstructured":"Hu MH, Wang YQ, Yu ZY, Hu LN, Ou TM, Chen SB, Huang ZS, Tan JH. Discovery of a new four-leaf clover-like ligand as a potent c-MYC transcription inhibitor specifically targeting the promoter G-quadruplex. J Med Chem. 2018;61:2447\u201359.","journal-title":"J Med Chem"},{"key":"9650_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Res Updat. 2018;38:1\u201311.","journal-title":"Drug Res Updat"},{"key":"9650_CR13","first-page":"718","volume":"43","author":"B Jiang","year":"2020","unstructured":"Jiang B, Yang B, Wang Q, Zheng X, Guo Y, Lu W. lncRNA PVT1 promotes hepatitis B virus-positive liver cancer progression by disturbing histone methylation on the c-Myc promoter. Oncol Rep. 2020;43:718\u201326.","journal-title":"Oncol Rep"},{"key":"9650_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet (london, England). 2019;393:1240\u201353.","journal-title":"Lancet (london, England)"},{"key":"9650_CR15","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1172\/JCI94233","volume":"127","author":"W Li","year":"2017","unstructured":"Li W, Zhang Z, Liu X, Cheng X, Zhang Y, Han X, Zhang Y, Liu S, Yang J, Xu B, He L, Sun L, Liang J, Shang Y. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Investig. 2017;127:3421\u201340.","journal-title":"J Clin Investig"},{"key":"9650_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13402-019-00486-4","volume":"43","author":"X Li","year":"2020","unstructured":"Li X, Tang M, Zhu Q, Wang X, Lin Y, Wang X. The exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration. Cell Oncol (dordr). 2020;43:263\u201377.","journal-title":"Cell Oncol (dordr)"},{"key":"9650_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/0008-5472.CAN-14-3607","volume":"76","author":"Y Li","year":"2016","unstructured":"Li Y, Wang Z, Shi H, Li H, Li L, Fang R, Cai X, Liu B, Zhang X, Ye L. HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc. Can Res. 2016;76:293\u2013304.","journal-title":"Can Res"},{"key":"9650_CR18","doi-asserted-by":"publisher","first-page":"12431","DOI":"10.1038\/ncomms12431","volume":"7","author":"J Liang","year":"2016","unstructured":"Liang J, Cao R, Zhang Y, Xia Y, Zheng Y, Li X, Wang L, Yang W, Lu Z. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nat Commun. 2016;7:12431.","journal-title":"Nat Commun"},{"key":"9650_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.tcb.2017.11.008","volume":"28","author":"C Lin","year":"2018","unstructured":"Lin C, Yang L. Long Noncoding RNA in Cancer: Wiring Signaling Circuitry. Trends Cell Biol. 2018;28:287\u2013301.","journal-title":"Trends Cell Biol"},{"key":"9650_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccell.2015.02.004","volume":"27","author":"B Liu","year":"2015","unstructured":"Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li D, Zeng M, Song E. A cytoplasmic NF-\u03baB interacting long noncoding RNA blocks I\u03baB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27:370\u201381.","journal-title":"Cancer Cell"},{"key":"9650_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-019-1329-2","volume":"38","author":"X Long","year":"2019","unstructured":"Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 2019;38:345\u201358.","journal-title":"J Exp Clin Cancer Res"},{"key":"9650_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.eururo.2013.12.003","volume":"65","author":"ES Martens-Uzunova","year":"2014","unstructured":"Martens-Uzunova ES, B\u00f6ttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65:1140\u201351.","journal-title":"Eur Urol"},{"key":"9650_CR23","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1158\/0008-5472.CAN-17-0498","volume":"77","author":"A M\u00e9ndez-Lucas","year":"2017","unstructured":"M\u00e9ndez-Lucas A, Li X, Hu J, Che L, Song X, Jia J, Wang J, Xie C, Driscoll PC, Tschaharganeh DF, Calvisi DF, Yuneva M, Chen X. Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1\/PKM2 Ratios and Pyruvate Kinase Activities. Can Res. 2017;77:4355\u201364.","journal-title":"Can Res"},{"key":"9650_CR24","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661\u20137.","journal-title":"Oncogene"},{"key":"9650_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"9650_CR26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3389\/fonc.2020.01034","volume":"10","author":"H Shi","year":"2020","unstructured":"Shi H, Li K, Feng J, Liu G, Feng Y, Zhang X. LncRNA-DANCR Interferes With miR-125b-5p\/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis. Front Oncol. 2020;10:1034\u201349.","journal-title":"Front Oncol"},{"key":"9650_CR27","doi-asserted-by":"crossref","unstructured":"Siegel, RL, KD Miller, and A Jemal. 2020. 'Cancer statistics, 2020', CA: Cancer J Clin, 70: 7\u201330.","DOI":"10.3322\/caac.21590"},{"key":"9650_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12920-020-0687-0","volume":"13","author":"S Smerekanych","year":"2020","unstructured":"Smerekanych S, Johnson TS, Huang K, Zhang Y. Pseudogene-gene functional networks are prognostic of patient survival in breast cancer. BMC Med Genomics. 2020;13:51.","journal-title":"BMC Med Genomics"},{"key":"9650_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1096\/fj.15-279166","volume":"30","author":"Q Tong","year":"2016","unstructured":"Tong Q, Gong AY, Zhang XT, Lin C, Ma S, Chen J, Hu G, Chen XM. LincRNA-Cox2 modulates TNF-\u03b1-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2\/NuRD-mediated epigenetic histone modifications. FASEB J. 2016;30:1187\u201397.","journal-title":"FASEB J"},{"key":"9650_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.drudis.2018.04.010","volume":"23","author":"MK Tripathi","year":"2018","unstructured":"Tripathi MK, Doxtater K, Keramatnia F, Zacheaus C, Yallapu MM, Jaggi M, Chauhan SC. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discovery Today. 2018;23:1635\u201343.","journal-title":"Drug Discovery Today"},{"key":"9650_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-019-0747-0","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang J, Xie S, Yang J, Xiong H, Jia Y, Zhou Y, Chen Y, Ying X, Chen C, Ye C, Wang L, Zhou J. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. J Hematol Oncol. 2019;12:81\u201390.","journal-title":"J Hematol Oncol"},{"key":"9650_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-021-01957-z","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Li X, Lin F, Sun H, Lin Y, Wang Z, Wang X. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40:151.","journal-title":"J Exp Clin Cancer Res"},{"key":"9650_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","volume":"18","author":"L Wei","year":"2019","unstructured":"Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M, Lei T, Zhang N, Yang M. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer. 2019;18:147\u201357.","journal-title":"Mol Cancer"},{"key":"9650_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","volume":"15","author":"CM Wong","year":"2018","unstructured":"Wong CM, Tsang FH, Ng IO. \u201cNon-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.\u201d Nat Rev Gastroenterol Hepatol. 2018;15:137\u201351.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9650_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","volume":"356","author":"N Wong","year":"2015","unstructured":"Wong N, Ojo D, Yan J, Tang D. PKM2 contributes to cancer metabolism. Cancer Lett. 2015;356:184\u201391.","journal-title":"Cancer Lett"},{"key":"9650_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41467-017-00902-z","volume":"8","author":"ZD Xiao","year":"2017","unstructured":"Xiao ZD, Han L, Lee H, Zhuang L, Zhang Y, Baddour J, Nagrath D, Wood CG, Gu J, Wu X, Liang H, Gan B. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun. 2017;8:783\u201394.","journal-title":"Nat Commun"},{"key":"9650_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-018-0910-4","volume":"37","author":"H Yan","year":"2018","unstructured":"Yan H, Li H, Li P, Li X, Lin J, Zhu L, Silva MA, Wang X, Wang P, Zhang Z. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375\/YAP1 axis. J Exp Clin Cancer Res. 2018;37:237\u201350.","journal-title":"J Exp Clin Cancer Res"},{"key":"9650_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","volume":"150","author":"W Yang","year":"2012","unstructured":"Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 2012a;150:685\u201396.","journal-title":"Cell"},{"key":"9650_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012b;14:1295\u2013304.","journal-title":"Nat Cell Biol"},{"key":"9650_CR40","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1002\/jcb.26899","volume":"119","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu Y, Xu X. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a\/hexokinase 2 pathway. J Cell Biochem. 2018;119:6296\u2013308.","journal-title":"J Cell Biochem"},{"key":"9650_CR41","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","volume":"77","author":"L Zhao","year":"2017","unstructured":"Zhao L, Ji G, Le X, Wang C, Xu L, Feng M, Zhang Y, Yang H, Xuan Y, Yang Y, Lei L, Yang Q, Lau WB, Lau B, Chen Y, Deng X, Yao S, Yi T, Zhao X, Wei Y, Zhou S. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. Can Res. 2017;77:1369\u201382.","journal-title":"Can Res"},{"key":"9650_CR42","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X, Wang H, Wang K, Lin Y, Wang X. Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg\/Th17 Cell Imbalance in Epithelial Ovarian Cancer. Cancer Immunol Res. 2018;6:1578\u201392.","journal-title":"Cancer Immunol Res"},{"key":"9650_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.stem.2009.04.001","volume":"4","author":"S Zhu","year":"2009","unstructured":"Zhu S, Wurdak H, Wang J, Lyssiotis CA, Peters EC, Cho CY, Wu X, Schultz PG. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell. 2009;4:416\u201326.","journal-title":"Cell Stem Cell"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-021-09650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-021-09650-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-021-09650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:13:55Z","timestamp":1671016435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-021-09650-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9650"],"URL":"https:\/\/doi.org\/10.1007\/s10565-021-09650-9","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,12]]},"assertion":[{"value":"7 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of XinHua Hospital Affiliated to the Shanghai JiaoTong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants were informed about the objectives and implications of the study before obtaining a signed written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No details, images, or videos relating to an individual person have been included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}